BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshida M, Funasaki H, Marumo K. Efficacy of autologous leukocyte-reduced platelet-rich plasma therapy for patellar tendinopathy in a rat treadmill model. Muscles Ligaments Tendons J 2016;6:205-15. [PMID: 27900294 DOI: 10.11138/mltj/2016.6.2.205] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
2 Kuffler DP. Variables affecting the potential efficacy of PRP in providing chronic pain relief. J Pain Res 2019;12:109-16. [PMID: 30613159 DOI: 10.2147/JPR.S190065] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
3 Vilar JM, Manera ME, Santana A, Spinella G, Rodriguez O, Rubio M, Carrillo JM, Sopena J, Batista M. Effect of leukocyte-reduced platelet-rich plasma on osteoarthritis caused by cranial cruciate ligament rupture: A canine gait analysis model. PLoS One 2018;13:e0194752. [PMID: 29554150 DOI: 10.1371/journal.pone.0194752] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
4 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Reference Citation Analysis]
5 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Reference Citation Analysis]
6 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Reference Citation Analysis]
7 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Reference Citation Analysis]
8 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Reference Citation Analysis]
9 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Reference Citation Analysis]
10 El Bakly W, Medhat M, Shafei M, Tash R, Elrefai M, Shoukry Y, Omar NN. Optimized platelet rich plasma releasate (O-rPRP) repairs galactosemia-induced ovarian follicular loss in rats by activating mTOR signaling and inhibiting apoptosis. Heliyon 2020;6:e05006. [PMID: 33005806 DOI: 10.1016/j.heliyon.2020.e05006] [Reference Citation Analysis]
11 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Reference Citation Analysis]
12 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Reference Citation Analysis]
13 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Reference Citation Analysis]
14 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci 2020;21:E7794. [PMID: 33096812 DOI: 10.3390/ijms21207794] [Reference Citation Analysis]